{"id":"https://openalex.org/W2005138940","doi":"https://doi.org/10.1021/ol9900111","title":"Synthesis of NBD-\u03b1-galactosylceramide and Its Immunologic Properties","display_name":"Synthesis of NBD-\u03b1-galactosylceramide and Its Immunologic Properties","alternate_titles":[],"publication_year":1999,"publication_date":"1999-06-23","ids":{"openalex":"https://openalex.org/W2005138940","doi":"https://doi.org/10.1021/ol9900111","mag":"2005138940","pmid":"https://pubmed.ncbi.nlm.nih.gov/10822576"},"language":"en","primary_location":{"id":"doi:10.1021/ol9900111","doi":"https://doi.org/10.1021/ol9900111","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ol9900111","pdf_url":null,"source":{"id":"https://openalex.org/S201989124","display_name":"Organic Letters","issn_l":"1523-7052","issn":["1523-7052","1523-7060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005138940"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113535056","display_name":"Teruyuki Sakai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Teruyuki Sakai","raw_affiliation_strings":["Pharmaceutical Reserach Laboratory, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Reserach Laboratory, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087193676","display_name":"Hiromi Ehara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiromi Ehara","raw_affiliation_strings":["Pharmaceutical Reserach Laboratory, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Reserach Laboratory, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111906226","display_name":"Yasuhiko Koezuka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802592688","display_name":"Kirin (Japan)","ror":"https://ror.org/0586k5242","country_code":"JP","type":"company","lineage":["https://openalex.org/I2802592688"]},{"id":"https://openalex.org/I4405274001","display_name":"Kirin Brewery Company, Limited (Japan)","ror":"https://ror.org/00vm6vn72","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405274001"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuhiko Koezuka","raw_affiliation_strings":["Pharmaceutical Reserach Laboratory, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Reserach Laboratory, Kirin Brewery Co., Ltd., 3 Miyahara-cho, Takasaki-shi, Gunma 370-1295, Japan","institution_ids":["https://openalex.org/I2802592688","https://openalex.org/I4405274001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4500,"currency":"USD","value_usd":4500},"apc_paid":null,"fwci":2.0465,"has_fulltext":false,"cited_by_count":43,"citation_normalized_percentile":{"value":0.83948523,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"1","issue":"3","first_page":"359","last_page":"362"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.8095999956130981,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10835","display_name":"Carbohydrate Chemistry and Synthesis","score":0.8095999956130981,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.09049999713897705,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11385","display_name":"Natural product bioactivities and synthesis","score":0.04439999908208847,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/alpha-galactosylceramide","display_name":"alpha-galactosylceramide","score":0.9549999833106995},{"id":"https://openalex.org/keywords/nkt-cell-activation","display_name":"NKT cell activation","score":0.8970000147819519},{"id":"https://openalex.org/keywords/cd1d","display_name":"CD1d","score":0.8899999856948853},{"id":"https://openalex.org/keywords/fluorescent-labeling","display_name":"fluorescent labeling","score":0.5529999732971191},{"id":"https://openalex.org/keywords/immune-enhancement","display_name":"immune enhancement","score":0.949999988079071},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.746999979019165},{"id":"https://openalex.org/keywords/glycolipid-biosynthesis","display_name":"glycolipid synthesis","score":0.7419999837875366}],"concepts":[{"id":"https://openalex.org/C2778607024","wikidata":"https://www.wikidata.org/wiki/Q4216825","display_name":"CD1D","level":5,"score":0.9002015590667725},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7034380435943604},{"id":"https://openalex.org/C102747710","wikidata":"https://www.wikidata.org/wiki/Q824237","display_name":"Endosome","level":3,"score":0.5856804847717285},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.5783755779266357},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4762863516807556},{"id":"https://openalex.org/C139563560","wikidata":"https://www.wikidata.org/wiki/Q224930","display_name":"Natural killer T cell","level":4,"score":0.46243464946746826},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.3595626652240753},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3487642705440521},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.23143455386161804},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17537322640419006},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.15952211618423462},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1257755160331726},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07586443424224854},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D000276","descriptor_name":"Adjuvants, Immunologic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005699","descriptor_name":"Galactosylceramides","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":true},{"descriptor_ui":"D005699","descriptor_name":"Galactosylceramides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007694","descriptor_name":"Killer Cells, Natural","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D009327","descriptor_name":"4-Chloro-7-nitrobenzofurazan","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009327","descriptor_name":"4-Chloro-7-nitrobenzofurazan","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D009327","descriptor_name":"4-Chloro-7-nitrobenzofurazan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013268","descriptor_name":"Stimulation, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018949","descriptor_name":"Antigens, CD1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1021/ol9900111","doi":"https://doi.org/10.1021/ol9900111","is_oa":false,"landing_page_url":"https://doi.org/10.1021/ol9900111","pdf_url":null,"source":{"id":"https://openalex.org/S201989124","display_name":"Organic Letters","issn_l":"1523-7052","issn":["1523-7052","1523-7060"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320006","host_organization_name":"American Chemical Society","host_organization_lineage":["https://openalex.org/P4310320006"],"host_organization_lineage_names":["American Chemical Society"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic Letters","raw_type":"journal-article"},{"id":"pmid:10822576","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10822576","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Organic letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8226000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1491069734","https://openalex.org/W1495638355","https://openalex.org/W1508427423","https://openalex.org/W1517751286","https://openalex.org/W1766534957","https://openalex.org/W1987275221","https://openalex.org/W2001657366","https://openalex.org/W2008446420","https://openalex.org/W2012365392","https://openalex.org/W2013857975","https://openalex.org/W2039226425","https://openalex.org/W2048724356","https://openalex.org/W2052178043","https://openalex.org/W2054662877","https://openalex.org/W2055971070","https://openalex.org/W2061947456","https://openalex.org/W2064858323","https://openalex.org/W2093497258","https://openalex.org/W2129821101","https://openalex.org/W2130295685","https://openalex.org/W2158117877","https://openalex.org/W2161307276","https://openalex.org/W2182062308","https://openalex.org/W4313310004"],"related_works":["https://openalex.org/W2054662877","https://openalex.org/W4248035038","https://openalex.org/W2093045545","https://openalex.org/W2099712864","https://openalex.org/W2395316602","https://openalex.org/W2149878643","https://openalex.org/W1968200099","https://openalex.org/W2522280564","https://openalex.org/W2028221734","https://openalex.org/W2410137874"],"abstract_inverted_index":{"[formula:":[0],"see":[1],"text]":[2],"A":[3],"representative":[4],"alpha-galactosylceramide":[5],"(alpha-GalCer),":[6],"KRN7000,":[7],"can":[8],"activate":[9],"NKT":[10],"cells":[11],"through":[12],"CD1d":[13,40,47],"molecules,":[14],"which":[15,60],"play":[16],"an":[17],"essential":[18],"role":[19],"in":[20,50],"the":[21,24,68],"generation":[22],"of":[23,28,78],"strong":[25,62],"antitumor":[26],"activity":[27,72],"KRN7000.":[29,79],"Our":[30],"previous":[31],"study":[32],"has":[33,61,70],"demonstrated":[34],"that":[35,67,73,77],"alpha-GalCer":[36,49],"binds":[37,48],"directly":[38],"to":[39],"molecules.":[41],"However,":[42],"it":[43],"is":[44,74],"controversial":[45],"whether":[46],"endosomal":[51],"compartments.":[52],"To":[53],"address":[54],"this":[55],"question,":[56],"we":[57],"synthesized":[58],"NBD-alpha-GalCer,":[59],"fluorescent":[63],"properties.":[64],"We":[65],"found":[66],"NBD-alpha-GalCer":[69],"immunostimulatory":[71],"stronger":[75],"than":[76]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005138940","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
